Clinical trial
NF-KB1/IKK Epsilon Genetic Expression in Patients With Rheumatoid Arthritis
NCT02689115 is registered in ClinicalTrials.gov with Asociación Científica Latina A.C. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NF-KB1/IKK Epsilon Genetic Expression in Patients With Rheumatoid Arthritis
- Lead sponsor
- Asociación Científica Latina A.C.
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2013
- Completion date
- December 31, 2015
- Enrollment
- 60 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis